RifatPamukcuMD
Gastroenterology • Spring House, PAPresident, CEO & Chaiman, Midway Pharmaceuticals, Inc.
Dr. Pamukcu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Pump House
Spring House, PA 19477Phone+1 215-628-0938
Education & Training
University of ChicagoFellowship, Gastroenterology, 1986 - 1989
Rush University Medical CenterResidency, Internal Medicine, 1983 - 1986
University of Wisconsin School of Medicine & Public HealthClass of 1983
Certifications & Licensure
PA State Medical License 1995 - 2024
OH State Medical License 1989 - 1996
IL State Medical License 1983 - 1990- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 60 citationsVasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G.Atsuko Deguchi, Jae Won Soh, Han Li, Rifat Pamukcu, W. Joseph Thompson
Molecular Cancer Therapeutics. 2002-08-01 - 97 citationsExisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis.Gary A. Piazza, W. Joseph Thompson, Rifat Pamukcu, Hector Alila, Clark M. Whitehead
Cancer Research. 2001-05-15 - 365 citationsAntineoplastic Drugs Sulindac Sulfide and Sulfone Inhibit Cell Growth by Inducing ApoptosisGary A. Piazza, Alanna Kulchak Rahm, Mary Krutzsch, Gerhard Sperl, Nancy Shipp Paranka
Cancer Research. 1995-07-15
Professional Memberships
- Member
- Member
- Member
Other Languages
- Turkish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
